Pfizer Inc (PFE)
28.94
+0.12
(+0.40%)
USD |
NYSE |
May 16, 16:00
28.96
+0.02
(+0.09%)
After-Hours: 16:38
Pfizer Market Cap: 163.96B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 15, 2024 | 163.31B |
| May 14, 2024 | 160.82B |
| May 13, 2024 | 161.16B |
| May 10, 2024 | 158.72B |
| May 09, 2024 | 159.68B |
| May 08, 2024 | 160.19B |
| May 07, 2024 | 157.36B |
| May 06, 2024 | 159.57B |
| May 03, 2024 | 157.59B |
| May 02, 2024 | 156.98B |
| May 01, 2024 | 154.03B |
| April 30, 2024 | 145.19B |
| April 29, 2024 | 145.30B |
| April 26, 2024 | 143.94B |
| April 25, 2024 | 143.15B |
| April 24, 2024 | 148.87B |
| April 23, 2024 | 149.16B |
| April 22, 2024 | 148.82B |
| April 19, 2024 | 147.34B |
| April 18, 2024 | 143.89B |
| April 17, 2024 | 144.06B |
| April 16, 2024 | 145.59B |
| April 15, 2024 | 146.83B |
| April 12, 2024 | 146.55B |
| April 11, 2024 | 149.27B |
| Date | Value |
|---|---|
| April 10, 2024 | 149.16B |
| April 09, 2024 | 151.76B |
| April 08, 2024 | 150.63B |
| April 05, 2024 | 151.08B |
| April 04, 2024 | 151.03B |
| April 03, 2024 | 154.26B |
| April 02, 2024 | 156.13B |
| April 01, 2024 | 157.09B |
| March 28, 2024 | 157.14B |
| March 27, 2024 | 157.31B |
| March 26, 2024 | 156.23B |
| March 25, 2024 | 155.32B |
| March 22, 2024 | 154.93B |
| March 21, 2024 | 156.63B |
| March 20, 2024 | 156.85B |
| March 19, 2024 | 156.46B |
| March 18, 2024 | 156.97B |
| March 15, 2024 | 158.21B |
| March 14, 2024 | 159.29B |
| March 13, 2024 | 159.80B |
| March 12, 2024 | 158.61B |
| March 11, 2024 | 160.65B |
| March 08, 2024 | 154.13B |
| March 07, 2024 | 151.70B |
| March 06, 2024 | 153.96B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.15B
Minimum
Apr 25 2024
343.79B
Maximum
Dec 16 2021
220.55B
Average
208.51B
Median
Market Cap Benchmarks
| Amgen Inc | 168.89B |
| Johnson & Johnson | 371.42B |
| Eli Lilly and Co | 731.81B |
| Viking Therapeutics Inc | 7.626B |
| Moderna Inc | 50.84B |
Market Cap Related Metrics
| PS Ratio | 2.981 |
| Price to Book Value | 1.777 |
| Price to Free Cash Flow | 32.16 |
| Price | 28.94 |
| Earnings Yield | -0.21% |
| Operating PE Ratio | 137.77 |
| Normalized PE Ratio | 48.33 |